Page 4 - ஓரிகந் ஆரோக்கியம் அறிவியல் பல்கலைக்கழகம் இல் போர்டிலந்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

email article Perioperative treatment to preserve nerve function did not significantly improve erectile function after surgery for prostate cancer, a randomized, placebo-controlled study showed. Six months after radical prostatectomy, patients treated with erythropoietin (EPO) or placebo had similar scores on a validated scale of erectile function. In fact, the median score favored the placebo group (19 vs 14). Investigators also found no significant difference between groups at 3, 9, and 12 months. Adjustment for nerve-sparing surgery, which was associated with recovery of erectile function, had minimal effect on analyses of primary and secondary endpoints. The EPO group had significantly higher hemoglobin levels during treatment, consistent with administration of EPO, reported Hiten D. Patel, MD, of Johns Hopkins School of Medicine in Baltimore, and co-authors in the

United statesCharles bankheadHitend patelMark garzottoPoones shoureshiOregon health science university in portlandJohns hopkins school of medicineInternational index of erectile functionJohns hopkins schoolOregon healthScience universityInternational indexErectile functionMedpage todayErectile dysfunctionRadical prostatectomy